Corporate News 26-Mar-24
Warren Remedies commences commercial production of its greenfield units at Aurangabad
Indoco Remedies announced that its wholly owned subsidiary, Warren Remedies has commenced its commercial production on 24 March 2024 from its greenfield manufacturing facility located at Aurangabad, Maharashtra to manufacture Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (APIs).
Previous News
Indoco Remedies standalone net profit rises 19.41% in the September 2022 quarter
( Results - Announcements 10-Nov-22 12:17 )
Indoco Remedies incorporates subsidiary named Warren Remedies
( Corporate News - 08-Jun-22 11:29 )
Indoco Remedies acquires 85% stake in US-based FPP Holding Company
( Corporate News - 06-Jun-23 08:56 )
Indoco Remedies gains after acquiring 85% stake US-based FPP Holding Company
( Hot Pursuit - 06-Jun-23 09:44 )
Indoco Remedies CFO resigns
( Corporate News - 11-Jun-21 17:27 )
Indoco Remedies gains on USFDA nod for type 2 diabetes drug
( Hot Pursuit - 06-Dec-23 15:33 )
Indoco Remedies to announce Quarterly Result
( Corporate News - 06-Jan-20 15:55 )
Indoco Remedies receives UKMHRA accreditation for its clinical research facility at Hyderabad
( Corporate News - 27-Aug-21 12:31 )
Indoco Remedies to hold board meeting
( Corporate News - 04-Mar-16 17:36 )
Indoco's Patalganga site gets Japanese Accreditation
( Corporate News - 04-Apr-18 18:51 )
Indoco Remedies rises after AnaCipher gets UKMHRA accreditation
( Hot Pursuit - 27-Aug-21 13:44 )
Other Stories
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Back
Top
